Found 27 matching trials
Psychopharmacotherapy for Depressive Patients NA The primary purpose of this study is to compare the short (12 week) and lon...
Show More Location
Chonnam National University Hospital
Learn More & Join Trial
Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression PHASE4 Our target population will have been adequately treated with one of three s...
Show More Location
University of Texas Southwestern Medical Center at Dallas
Learn More & Join Trial
Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole NA This randomized, single-blind (assessor-blind) controlled trial aims to inv...
Show More Status
Active Not Recruiting
Location
The Second Xiangya Hospital of Central South University
Learn More & Join Trial
Multimodal Magnetic Resonance Imaging-based Study of Electroconvulsive Efficacy Prediction in Adolescents With Depression: a Multicenter Prospective Cohort Study N/A The aim of this project is to investigate the multimodal magnetic resonance...
Show More Location
The First Affiliated Hospital of Chongqing Medical University
Learn More & Join Trial
Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. PHASE4 The effectiveness and efficacy of the combination of pharmacotherapy with t...
Show More Status
Active Not Recruiting
Location
Private practice of Dr. S. Rakitzi and Dr. P. Georgila ILISION 34 15771 ATHENS GREECE
Treatments Being Tested
Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram), Group B (Pharmacotherapy and TAU) (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, antidepressants, Group C (Pharmacotherapy and Psychotherapy) Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, lithium, depakine Group D (Pharmacotherapy and TAU)Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, seropram, lithium, depakine) Learn More & Join Trial
To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD) PHASE3 This is a multicenter, 52-week, open-label study designed to assess the saf...
Show More Location
Multiple Locations
Learn More & Join Trial
Canadian Biomarker Integration Network for Depression Study PHASE3 This study is a pilot to assess feasibility of the protocol in patients and...
Show More Location
University of Calgary
Learn More & Join Trial
Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD) PHASE3 This will be a multicenter, randomized, double-blind study designed to asse...
Show More Location
Multiple Locations
Learn More & Join Trial
Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on Anhedonia NA This study is a multicenter clinical research and focuses on the exploring ...
Show More Location
Beijing Xicheng District Pingan Hosptial
Learn More & Join Trial
Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism PHASE4 Reduction of volume of the hippocampus has been associated with major depre...
Show More Location
University of Ottawa Institute of Mental Health Research
Learn More & Join Trial